Published in Drug Week, January 5th, 2007
The new MEM 3454 data were presented during the "Hot Topics" portion of the meeting and in two poster presentations. These results define dose-response relationships and minimally effective doses in microdialysis measurements of dopamine and acetylcholine release in rat medial prefrontal cortex and hippocampus. The preclinical data also demonstrate that MEM 3454 has an additive effect on both dopamine and acetylcholine release when...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.